UBTD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.014400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.639000E-01
Normal-vs-Stage2
8.282800E-01
Normal-vs-Stage3
7.208200E-01
Normal-vs-Stage4
4.731800E-01
Stage1-vs-Stage2
6.300000E-01
Stage1-vs-Stage3
9.368200E-01
Stage1-vs-Stage4
9.616300E-02
Stage2-vs-Stage3
6.334600E-01
Stage2-vs-Stage4
5.578400E-02
Stage3-vs-Stage4
1.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.661200E-01
Normal-vs-AfricanAmerican
9.502600E-01
Normal-vs-Asian
6.790000E-01
Caucasian-vs-AfricanAmerican
5.797800E-01
Caucasian-vs-Asian
6.372800E-01
AfricanAmerican-vs-Asian
4.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.908600E-01
Normal-vs-Female
8.332200E-01
Male-vs-Female
6.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.000200E-01
Normal-vs-Age(41-60Yrs)
7.294000E-01
Normal-vs-Age(61-80Yrs)
6.474400E-01
Normal-vs-Age(81-100Yrs)
6.157800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.998600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.910000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.938600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.155400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.095720E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.847240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.946200E-01
Normal-vs-Daily Drinker
3.353000E-01
Normal-vs-Weekly Drinker
9.133400E-01
Normal-vs-Occasional Drinker
8.065000E-01
Normal-vs-Social Drinker
9.529400E-01
Non Drinker-vs-Daily Drinker
4.221000E-01
Non Drinker-vs-Weekly Drinker
4.352000E-01
Non Drinker-vs-Occasional Drinker
6.070800E-01
Non Drinker-vs-Social Drinker
2.419000E-01
Daily Drinker-vs-Weekly Drinker
1.420810E-01
Daily Drinker-vs-Occasional Drinker
2.277200E-01
Daily Drinker-vs-Social Drinker
6.186400E-02
Weekly Drinker-vs-Occasional Drinker
7.983600E-01
Weekly Drinker-vs-Social Drinker
7.563000E-01
Occasional Drinker-vs-Social Drinker
5.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.334400E-02
Normal-vs-Grade 2
3.218600E-03
Normal-vs-Grade 3
2.216200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.435000E-04
Grade 1-vs-Grade 3
1.569530E-02
Grade 1-vs-Grade 4
8.334400E-02
Grade 2-vs-Grade 3
6.628000E-01
Grade 2-vs-Grade 4
3.218600E-03
Grade 3-vs-Grade 4
2.216200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.781800E-01
Normal-vs-NonDiabetic
7.919600E-01
Diabetic-vs-NonDiabetic
2.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.469200E-01
Normal-vs-NoPancreatitis
7.773000E-01
Pancreatitis-vs-NoPancreatitis
9.155200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.338400E-01
Normal-vs-N1
9.101000E-01
N0-vs-N1
1.704180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.729200E-01
Normal-vs-TP53-NonMutant
7.438800E-01
TP53-Mutant-vs-TP53-NonMutant
3.243400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
